Dyslipidemia Withdrawn Phase 4 Trials for Atorvastatin (DB01076)

Also known as: Dyslipaemia / Dyslipidaemia / Dyslipidemias / Dyslipidaemias

IndicationStatusPhase
DBCOND0020718 (Dyslipidemia)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03047538Fixed Combination for Lipid and Blood Pressure ControlTreatment
NCT03750760Early Alirocumab to Reduce LDL-C in Myocardial InfarctionTreatment